New Zealand COPD Guidelines: Quick Reference Guide.


Journal

The New Zealand medical journal
ISSN: 1175-8716
Titre abrégé: N Z Med J
Pays: New Zealand
ID NLM: 0401067

Informations de publication

Date de publication:
19 02 2021
Historique:
entrez: 2 3 2021
pubmed: 3 3 2021
medline: 17 3 2021
Statut: epublish

Résumé

The purpose of the Asthma and Respiratory Foundation of New Zealand's COPD Guidelines: Quick Reference Guide is to provide simple, practical, evidence-based recommendations for the diagnosis, assessment, and management of chronic obstructive pulmonary disease (COPD) in clinical practice. The intended users are health professionals responsible for delivering acute and chronic COPD care in community and hospital settings, and those responsible for the training of such health professionals.

Identifiants

pubmed: 33651780

Types de publication

Guideline Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

76-110

Déclaration de conflit d'intérêts

Dr Young reports: I receive honorarium from GSK for giving educational talks on COPD management or attending advisory meetings. However, this did not impact on my contri-bution to this guideline. Dr Baggott reports personal fees from Astra Zeneca, personal fees from Novartis, outside the submitted work. Nicola Corna reports other from Boehring-er Ingelheim, other from Astra Zeneca, other from Astra Zeneca, grants from Adherium, outside the submitted work. Dr Fingleton reports grants, personal fees and non-financial support from AstraZeneca, grants from Genentech, grants, personal fees and non-financial support from GlaxoSmithKline, personal fees and non-financial support from Boheringer lngleheim, outside the submitted work. Dr Hardy reports non-financial support from As-trazeneca, outside the submitted work. Dr Hancox reports grants from Astra Zeneca, grants from GlaxoSmithKline, personal fees from Menarini, other from Boehringer Ingelheim, outside the submitted work.

Auteurs

Robert J Hancox (RJ)

Waikato District Health Board, Hamilton; University of Otago, Dunedin.

Stuart Jones (S)

Middlemore Hospital, Counties Manukau, Auckland.

Christina Baggott (C)

Medical Research Institute of New Zealand.

David Chen (D)

Canterbury Clinical Network, Christchurch.

Nicola Corna (N)

Middlemore Hospital, Counties Manukau, Auckland.

Cheryl Davies (C)

Tu Kotahi Māori Asthma Trust.

James Fingleton (J)

Medical Research Institute of New Zealand; Capital & Coast District Health Board, Wellington.

Jo Hardy (J)

Medical Research Institute of New Zealand.

Syed Hussain (S)

Auckland District Health Board.

Betty Poot (B)

Hutt Valley District Health Board, Lower Hutt; School of Nursing, Midwifery and Health Practice, Victoria University of Wellington, Wellington.

Jim Reid (J)

University of Otago, Dunedin; Best Practice Advisory Centre (BPAC), Dunedin.

Justin Travers (J)

Hutt Valley District Health Board, Lower Hutt.

Joanna Turner (J)

Asthma and Respiratory Foundation of New Zealand.

Robert Young (R)

Auckland District Health Board.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH